Dianthus Therapeutics (DNTH) Change in Cash (2017 - 2025)

Dianthus Therapeutics' Change in Cash history runs 9 years deep, the most recent figure standing at $42.7 million for Q3 2025.

• On a quarterly basis, Change in Cash rose 115.23% year-over-year to $42.7 million in Q3 2025; TTM through Sep 2025 was $22.3 million, a 118.02% increase from a year earlier, with the FY2024 full-year figure at -$109.4 million, down 193.5% from the prior year.
• Change in Cash grew to $42.7 million in Q3 2025 per DNTH's latest filing, from $3.1 million in the prior quarter.
• Across five years, Change in Cash topped out at $197.4 million in Q1 2024 and bottomed at -$280.3 million in Q3 2024.
• The 5-year median for Change in Cash is -$8.9 million (2021), against an average of $6.4 million.
• Biggest YoY gain for Change in Cash was 4136.37% in 2022; the steepest drop was 575.67% in 2022.
• Year by year, Change in Cash stood at -$25.9 million in 2021, then increased by 16.89% to -$21.5 million in 2022, then slipped by 15.99% to -$25.0 million in 2023, then surged by 56.41% to -$10.9 million in 2024, then surged by 492.38% to $42.7 million in 2025.
• Per Business Quant, the three latest DNTH Change in Cash figures stand at $42.7 million (Q3 2025), $3.1 million (Q2 2025), and -$12.7 million (Q1 2025).